Coronary diseaseLesion typeBifurcations

03/03 | SOLACI Webinar – Left Main PCI and Bifurcations: LATAM Bif Registry

solaci
solaci
767
0

We invite you to participate in the first free SOLACI virtual event of 2021. It is carried out with the support of Abbott, Boston Scientific, Medtronic and Terumo Interventional Systems and will have the participation of prestigious hemodynamicists from Latin America and the world.

The title of the event is: “Left Main PCI and Bifurcations: LATAM Bif Registry“.

The event will take place next Wednesday, March 3 at 5:00 p.m. (Argentine time).

The event is open and free and requires prior registration.

Check the program and register!

Register Here
SOLACI Webinar - Left Main PCI and Bifurcations: LATAM Bif Registry

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
Regression of High-Risk Plaque with Lifestyle Changes
Next article
Asymptomatic Patients: The Key to Understand the Prevalence of the COVID-19 Pandemic
solaci
solaci

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Dr. Omar Tupayachi - 0
Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

solaci - 0
The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

Dr. Andrés Rodríguez - 0
After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

Dr. Andrés Rodríguez - 0
In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Acute coronary syndromes

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically...
Dr. Omar Tupayachi -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Dr. Omar Tupayachi - 0
Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Dr. Juan Manuel Pérez - 0
Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

Dr. Andrés Rodríguez - 0
After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...